136 related articles for article (PubMed ID: 32969129)
1. Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma.
Margalit O; Shacham-Shmueli E; Yang YX; Lawerence YR; Levy I; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Mamtani R; Boursi B
Oncologist; 2021 Jan; 26(1):e111-e114. PubMed ID: 32969129
[TBL] [Abstract][Full Text] [Related]
2. Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma.
Margalit O; Shacham-Shmueli E; Strauss G; Yang YX; Lawrence YR; Ben Nun A; Levy I; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Mamtani R; Boursi B
Cancer Invest; 2023 Sep; 41(8):734-738. PubMed ID: 37665657
[TBL] [Abstract][Full Text] [Related]
3. The Discordance of Clinical and Pathologic Staging in Locally Advanced Gastric Adenocarcinoma.
Papageorge MV; de Geus SWL; Zheng J; Woods AP; Ng SC; Cassidy MR; McAneny D; Tseng JF; Sachs TE
J Gastrointest Surg; 2021 Jun; 25(6):1363-1369. PubMed ID: 33846934
[TBL] [Abstract][Full Text] [Related]
4. Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.
Samson P; Puri V; Robinson C; Lockhart C; Carpenter D; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T
Ann Thorac Surg; 2016 Jun; 101(6):2102-11. PubMed ID: 27083246
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival.
Crabtree TD; Yacoub WN; Puri V; Azar R; Zoole JB; Patterson GA; Krupnick AS; Kreisel D; Meyers BF
Ann Thorac Surg; 2011 May; 91(5):1509-15; discussion 1515-6. PubMed ID: 21435632
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
Wang YK; Wang YC; Shan F; Tang L; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):152-157. PubMed ID: 32074795
[No Abstract] [Full Text] [Related]
7. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
8. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
10. Risk factors for stage underestimation in patients with clinical T1N0 gastric cancer.
Kunishige T; Migita K; Matsumoto S; Wakatsuki K; Nakade H; Miyao S; Sho M
Surg Today; 2020 Sep; 50(9):1074-1080. PubMed ID: 32107643
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic characteristics and prognosis of gastric hepatoid adenocarcinoma].
Zhao R; Wang X; Lan X; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1035-1039. PubMed ID: 28900996
[TBL] [Abstract][Full Text] [Related]
12. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
13. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer.
Bentrem D; Gerdes H; Tang L; Brennan M; Coit D
Ann Surg Oncol; 2007 Jun; 14(6):1853-9. PubMed ID: 17357856
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma.
Derieux S; Svrcek M; Manela S; Lagorce-Pages C; Berger A; André T; Taieb J; Paye F; Voron T
Dig Liver Dis; 2020 Jan; 52(1):107-114. PubMed ID: 31427088
[TBL] [Abstract][Full Text] [Related]
16. Inaccurate Clinical Stage Is Common for Gastric Adenocarcinoma and Is Associated with Undertreatment and Worse Outcomes.
Ju MR; Karalis JD; Blackwell JM; Mansour JC; Polanco PM; Augustine M; Yopp AC; Zeh HJ; Wang SC; Porembka MR
Ann Surg Oncol; 2021 May; 28(5):2831-2843. PubMed ID: 33389294
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma.
Sada YH; Smaglo BG; Tan JC; Tran Cao HS; Musher BL; Massarweh NN
J Natl Compr Canc Netw; 2019 Feb; 17(2):161-168. PubMed ID: 30787129
[No Abstract] [Full Text] [Related]
18. Preoperative staging of gastric cancer by endoscopic ultrasound: the prognostic usefulness of ascites detected by endoscopic ultrasound.
Chen CH; Yang CC; Yeh YH
J Clin Gastroenterol; 2002 Oct; 35(4):321-7. PubMed ID: 12352295
[TBL] [Abstract][Full Text] [Related]
19. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum prostate-specific antigen and Gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: implications for the choice of primary treatment.
Ennis RD; Flynn SD; Fischer DB; Peschel RE
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):317-22. PubMed ID: 7523342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
